Scientists from the Walter Reed Army Institute of Research have demonstrated that this novel, second-generation TMV malaria vaccine candidate may offer protection against Plasmodium falciparum malaria – one of the four different species of Plasmodium parasite that causes malaria in humans.  Malaria, infecting approximately 228 million individuals in 2018, remains a meaningful threat to public health and …